Biggest News Aggregation in the World
📰 Hookipa Pharma News

Page 4 - Hookipa Pharma News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Hookipa Pharma. Real-time updates on events, politics, business and more.

HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May

04.05.2023 - NEW YORK and VIENNA, Austria, May 04, 2023 (GLOBE NEWSWIRE) - HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that HOOKIPA’s ... Seite 1
New York United States Pharma Inc Securities Life Sciences Conference Life Sciences Conference Markets Global Healthcare Conference

Susquehanna International Group LLP Raises Position in Hookipa Pharma Inc (NASDAQ:HOOK)

Susquehanna International Group LLP raised its holdings in shares of Hookipa Pharma Inc (NASDAQ:HOOK – Get Rating) by 99.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 45,014 shares of the company’s stock after buying an additional 22,450 shares during the […]
Hookipa Pharma Pharma Inc Millennium Management Susquehanna International Group Goldman Sachs Group Inc Securities Exchange Commission
Source: wkrb13.com

Hookipa Pharma (NASDAQ:HOOK) Trading Down 1%

Hookipa Pharma Inc (NASDAQ:HOOK – Get Rating) traded down 1% on Wednesday . The company traded as low as $0.72 and last traded at $0.72. 80,573 shares were traded during mid-day trading, a decline of 55% from the average session volume of 178,531 shares. The stock had previously closed at $0.73. Analyst Upgrades and Downgrades […]
Hookipa Pharma Vanguard Group Inc Hookipa Pharma Inc Millennium Management Alyeska Investment Group Jefferies Financial Group Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Hookipa Pharma Inc (NASDAQ:HOOK) Given Average Rating of "Buy" by Analysts

Shares of Hookipa Pharma Inc (NASDAQ:HOOK – Get Rating) have received a consensus recommendation of “Buy” from the nine ratings firms that are currently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year price […]
Hookipa Pharma Hookipa Pharma Inc Alyeska Investment Group Goldman Sachs Group Inc Mirabella Financial Services Zacks Investment Research

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science